PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction.

Giuseppe LombardiAlessandro SpimpoloSara BertiCristina CampiMaria Giulia AnglaniRossella SimeoneLaura EvangelistaFrancesco CausinGiovanni ZorziGiancarlo GorgoniMario CacceseMarta PadovanVittorina ZagonelDiego Cecchin

Published in: The British journal of radiology (2021)

Simultaneous evaluation of [18F]FET and ADC metrics using PET/MR allows an early and reliable identification of response to treatment and predict overall survival.

Keyphrases

contrast enhanced
diffusion weighted
diffusion weighted imaging
computed tomography
positron emission tomography
pet ct
magnetic resonance imaging
magnetic resonance
free survival
pet imaging
metastatic colorectal cancer